189 related articles for article (PubMed ID: 30962549)
1. Targeting chromatin complexes in fusion protein-driven malignancies.
Brien GL; Stegmaier K; Armstrong SA
Nat Rev Cancer; 2019 May; 19(5):255-269. PubMed ID: 30962549
[TBL] [Abstract][Full Text] [Related]
2. Chromosomal aberrations and fusion genes in myeloid malignancies.
Gianfelici V; Lahortiga I; Cools J
Expert Rev Hematol; 2012 Aug; 5(4):381-93. PubMed ID: 22992233
[TBL] [Abstract][Full Text] [Related]
3. Chromosomal aberrations in solid tumors.
Chinnaiyan AM; Palanisamy N
Prog Mol Biol Transl Sci; 2010; 95():55-94. PubMed ID: 21075329
[TBL] [Abstract][Full Text] [Related]
4. Fusion oncogenes in tumor development.
Aman P
Semin Cancer Biol; 2005 Jun; 15(3):236-43. PubMed ID: 15826838
[TBL] [Abstract][Full Text] [Related]
5. The discovery of common recurrent transmembrane protease serine 2 (TMPRSS2)-erythroblastosis virus E26 transforming sequence (ETS) gene fusions in prostate cancer: significance and clinical implications.
Shah RB; Chinnaiyan AM
Adv Anat Pathol; 2009 May; 16(3):145-53. PubMed ID: 19395877
[TBL] [Abstract][Full Text] [Related]
6. ETV6 gene aberrations in non-haematological malignancies: A review highlighting ETV6 associated fusion genes in solid tumors.
Biswas A; Rajesh Y; Mitra P; Mandal M
Biochim Biophys Acta Rev Cancer; 2020 Aug; 1874(1):188389. PubMed ID: 32659251
[TBL] [Abstract][Full Text] [Related]
7. Small Molecule Inhibitors as Therapeutic Agents Targeting Oncogenic Fusion Proteins: Current Status and Clinical.
Kong Y; Jiang C; Wei G; Sun K; Wang R; Qiu T
Molecules; 2023 Jun; 28(12):. PubMed ID: 37375228
[TBL] [Abstract][Full Text] [Related]
8. Emerging roles for chromatin remodeling in cancer biology.
Cairns BR
Trends Cell Biol; 2001 Nov; 11(11):S15-21. PubMed ID: 11684437
[TBL] [Abstract][Full Text] [Related]
9. Oncogenic fusion proteins and their role in three-dimensional chromatin structure, phase separation, and cancer.
Quiroga IY; Ahn JH; Wang GG; Phanstiel D
Curr Opin Genet Dev; 2022 Jun; 74():101901. PubMed ID: 35427897
[TBL] [Abstract][Full Text] [Related]
10. TAD disruption as oncogenic driver.
Valton AL; Dekker J
Curr Opin Genet Dev; 2016 Feb; 36():34-40. PubMed ID: 27111891
[TBL] [Abstract][Full Text] [Related]
11. Commonality but diversity in cancer gene fusions.
Rabbitts TH
Cell; 2009 May; 137(3):391-5. PubMed ID: 19410533
[TBL] [Abstract][Full Text] [Related]
12. Genetic lesions and perturbation of chromatin architecture: a road to cell transformation.
Chakraborty S; Senyuk V; Nucifora G
J Cell Biochem; 2001; 82(2):310-25. PubMed ID: 11527156
[TBL] [Abstract][Full Text] [Related]
13. Chromatin dependencies in cancer and inflammation.
Marazzi I; Greenbaum BD; Low DHP; Guccione E
Nat Rev Mol Cell Biol; 2018 Apr; 19(4):245-261. PubMed ID: 29184195
[TBL] [Abstract][Full Text] [Related]
14. Whole-genome doubling drives oncogenic loss of chromatin segregation.
Lambuta RA; Nanni L; Liu Y; Diaz-Miyar J; Iyer A; Tavernari D; Katanayeva N; Ciriello G; Oricchio E
Nature; 2023 Mar; 615(7954):925-933. PubMed ID: 36922594
[TBL] [Abstract][Full Text] [Related]
15. Oncogenic chromosomal translocations and human cancer (review).
Zheng J
Oncol Rep; 2013 Nov; 30(5):2011-9. PubMed ID: 23970180
[TBL] [Abstract][Full Text] [Related]
16. Detecting and targetting oncogenic fusion proteins in the genomic era.
Davare MA; Tognon CE
Biol Cell; 2015 May; 107(5):111-29. PubMed ID: 25631473
[TBL] [Abstract][Full Text] [Related]
17. Oncogenic fusion proteins adopt the insulin-like growth factor signaling pathway.
Werner H; Meisel-Sharon S; Bruchim I
Mol Cancer; 2018 Feb; 17(1):28. PubMed ID: 29455671
[TBL] [Abstract][Full Text] [Related]
18. [Fusion genes and transcripts in neoplasia].
Kekeeva TV; Zavalishina LÉ; Frank GA; Zaletaev DV
Mol Biol (Mosk); 2011; 45(5):793-804. PubMed ID: 22393775
[TBL] [Abstract][Full Text] [Related]
19. Functions, aberrations, and advances for chromatin modulation in cancer.
Conte M; Altucci L
Cancer Treat Res; 2014; 159():227-39. PubMed ID: 24114483
[TBL] [Abstract][Full Text] [Related]
20. Targeting the undruggable: exploiting neomorphic features of fusion oncoproteins in childhood sarcomas for innovative therapies.
Knott MML; Hölting TLB; Ohmura S; Kirchner T; Cidre-Aranaz F; Grünewald TGP
Cancer Metastasis Rev; 2019 Dec; 38(4):625-642. PubMed ID: 31970591
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
